These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


109 related items for PubMed ID: 1915542

  • 1. Serum immunosuppressive acidic protein as a tumor marker for renal cell carcinoma.
    Igarashi T, Murakami S, Isaka S, Okano T, Shimazaki J, Matsuzaki O.
    Eur Urol; 1991; 19(4):332-5. PubMed ID: 1915542
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Serum immunosuppressive acidic protein doubling time as a prognostic factor for recurrent renal cell carcinoma after nephrectomy.
    Araki K, Igarashi T, Tobe T, Mizoguchi K, Suzuki H, Furuya Y, Ichikawa T, Nakatsu HO, Ito H.
    Urology; 2006 Dec; 68(6):1178-82. PubMed ID: 17141843
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Serum level of immunosuppressive acidic protein in haemodialysis patients with or without renal cell carcinoma.
    Sasagawa I, Nakada T, Kubota Y, Suzuki H, Sawamura T.
    Br J Urol; 1994 Apr; 73(4):355-7. PubMed ID: 8199820
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Predictive values of acute phase reactants, basic fetoprotein, and immunosuppressive acidic protein for staging and survival in renal cell carcinoma.
    Miyata Y, Koga S, Nishikido M, Noguchi M, Kanda S, Hayashi T, Saito Y, Kanetake H.
    Urology; 2001 Aug; 58(2):161-4. PubMed ID: 11489689
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Serum immunosuppressive acidic protein in renal cell carcinoma.
    Ueda T.
    Urol Res; 1986 Aug; 14(2):101-3. PubMed ID: 3727211
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Serum immunosuppressive acidic protein and natural killer cell activity in patients with metastatic renal cell carcinoma before and after nephrectomy.
    Fujikawa K, Matsui Y, Miura K, Kobayashi T, Oka H, Fukuzawa S, Takeuchi H.
    J Urol; 2000 Sep; 164(3 Pt 1):673-5. PubMed ID: 10953123
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Serum basic fetoprotein in patients with renal cell carcinoma.
    Gohji K, Ishii M, Nagata H, Matsumoto O, Kamidono S.
    Cancer; 1990 Mar 15; 65(6):1405-11. PubMed ID: 1689608
    [Abstract] [Full Text] [Related]

  • 17. Higher Serum C-reactive Protein Level Represents the Immunosuppressive Tumor Microenvironment in Patients With Clear Cell Renal Cell Carcinoma.
    Nakayama T, Saito K, Kumagai J, Nakajima Y, Kijima T, Yoshida S, Kihara K, Fujii Y.
    Clin Genitourin Cancer; 2018 Dec 15; 16(6):e1151-e1158. PubMed ID: 30213543
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Immunosuppressive substance in the sera of head and neck cancer patients.
    Yamanaka N, Harabuchi Y, Himi T, Kataura A.
    Cancer; 1988 Oct 01; 62(7):1293-8. PubMed ID: 3416271
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.